Valuation: Edwards Lifesciences Corporation

Market Cap 58.56B 53.34B 49.15B 44.71B 83.87B 5,423B 88.15B 598B 238B 2,962B 220B 215B 9,296B P/E 2026 *
43.9x
P/E 2027 * 31.3x
Enterprise Value 55.06B 50.15B 46.21B 42.04B 78.86B 5,099B 82.88B 562B 224B 2,785B 207B 202B 8,740B EV / Sales 2026 *
8.09x
EV / Sales 2027 * 7.15x
Free-Float
86.54%
Yield 2026 *
-
Yield 2027 * -
1 day-1.95%
1 week-4.95%
Current month+10.69%
1 month+15.21%
3 months+13.43%
6 months+22.42%
Current year+19.47%
1 week 101.65
Extreme 101.65
108
1 month 87.9
Extreme 87.9
108
Current year 74.66
Extreme 74.66
108
1 year 74.66
Extreme 74.66
108
3 years 58.93
Extreme 58.93
108
5 years 58.93
Extreme 58.93
131.73
10 years 27.04
Extreme 27.04
131.73
Manager TitleAgeSince
Chief Executive Officer 58 2023-05-10
Director of Finance/CFO 43 2026-05-28
Chief Tech/Sci/R&D Officer 51 2025-08-31
Director TitleAgeSince
Chairman 69 2024-05-06
Director/Board Member 62 2015-02-09
Director/Board Member 58 2023-05-10
Date Insider Type Main position Quantity % Market Cap. Importance
10/8/26 Exercice

Executive/Senior Manager

1,857 0.0003%
9/14/26 Tax

Executive/Senior Manager

-568 0.0001%
9/13/26 Tax

Controller/Auditor

-253 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-1.95%-4.95%+19.64%+52.11% 58.56B
-2.79%-4.38%+13.97%+38.80% 248B
-3.16%-5.43%-3.09%+1.15% 155B
-2.01%-10.04%-28.95%+27.97% 138B
-2.35%-5.32%-56.67%-24.11% 60.85B
-1.96%-2.25%+2.85%-14.73% 52.46B
-2.83%-2.06%+12.65%+37.49% 48.04B
-3.51%-4.30%+11.79%+60.37% 43.29B
+1.26%-11.71%+9.08%+50.92% 43.1B
-1.53%-2.87%+5.48%+9.89% 36.46B
Average -2.08%-4.08%-1.32%+23.99% 88B
Weighted average by Cap. -2.39%-3.83%-1.65%+24.26%

Financials

2026 *2027 *
Net sales 6.81B 6.2B 5.72B 5.2B 9.75B 631B 10.25B 69.56B 27.65B 344B 25.55B 25.01B 1,081B 7.48B 6.81B 6.28B 5.71B 10.71B 693B 11.26B 76.4B 30.37B 378B 28.07B 27.47B 1,187B
Net income 1.34B 1.22B 1.13B 1.03B 1.93B 125B 2.02B 13.73B 5.46B 68.01B 5.05B 4.94B 213B 1.86B 1.69B 1.56B 1.42B 2.66B 172B 2.79B 18.97B 7.54B 93.92B 6.97B 6.82B 295B
Net Debt -3.5B -3.19B -2.94B -2.67B -5.01B -324B -5.27B -35.76B -14.21B -177B -13.13B -12.86B -556B -5.08B -4.62B -4.26B -3.87B -7.27B -470B -7.64B -51.84B -20.6B -257B -19.04B -18.64B -806B
Projected Income Statement - Annual - Edwards Lifesciences Corporation
Logo Edwards Lifesciences Corporation
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (74%); - hemodynamic monitoring systems (9.1%); - other (16.9%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (25%), Japan (5.8%) and other (10.8%).
Employees
16,000
Date Price Change Volume
26-11-20 US$101.85 -1.95% 3,621,036
26-11-19 US$103.88 -1.28% 3,700,852
26-11-18 US$105.23 -0.19% 3,923,271
26-11-17 US$105.43 -1.57% 4,272,484
26-11-16 US$107.11 -0.04% 4,544,597
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - Edwards Lifesciences Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
30
Last Close Price
101.85USD
Average target price
113.83USD
Spread / Average Target
+11.76%